• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 295/14 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Patent holdings for IPC class C07D 295/14

Total number of patents in this class: 163

10-year publication summary

12
4
4
4
4
4
10
8
6
0
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Alnylam Pharmaceuticals, Inc.
1153
17
Daiichi Sankyo Company, Limited
1859
8
Takeda Pharmaceutical Company Limited
2707
7
Astellas Pharma Inc.
1088
6
Abbvie Inc.
1803
5
Toyama Chemical Co., Ltd.
102
5
Boehringer Ingelheim International GmbH
4705
3
Pfizer Inc.
3371
3
Abbott Laboratories
2411
3
Taisho Pharmaceutical Co., Ltd.
869
3
SK on Co., Ltd.
1580
3
Janssen Pharmaceutica N.V.
3407
2
Actavis Group PTC ehf
471
2
Arena Pharmaceuticals, Inc.
366
2
Bioprojet
44
2
Dainippon Sumitomo Pharma Co., Ltd.
195
2
Dongjin Semichem Co., Ltd.
481
2
Galderma Research & Development
405
2
Gifu University
133
2
Kyoto Pharmaceutical Industries, Ltd.
19
2
Other owners 82